Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02230306 |
| Title | Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases |
| Acronym | CoBRIM-B |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Hussein Tawbi |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Harriet Kluger | New Haven | Connecticut | 06510 | United States | Details | |
| Mohammed Milhem, MD | Iowa City | Iowa | 52242 | United States | Details | |
| Anna Pavlick, MD | New York | New York | 10016 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Ravi Amaravadi, MD | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | United States | Details |